4月中成药制造概念4月股市资讯复盘讯息:
2021-04-29复盘:普遍报跌
嘉应制药(6.440,-0.720,-10.056%)领跌,千金药业(9.270,-0.370,-3.838%)、同仁堂(28.550,-0.250,-0.868%)、特一药业(12.230,-0.050,-0.407%)等跟跌。
2021-04-28复盘:普遍报涨
片仔癀(344.580,10.860,3.254%)领涨,同仁堂(28.810,0.460,1.623%)、千金药业(9.640,0.150,1.581%)等跟涨。
2021-04-27复盘:普遍报涨
中新药业(22.800,1.490,6.992%)领涨,片仔癀(333.720,5.670,1.728%)、千金药业(9.490,0.060,0.636%)等跟涨。
2021-04-26复盘:普遍报跌
片仔癀(328.050,-16.760,-4.861%)领跌,特一药业(13.310,-0.590,-4.245%)、同仁堂(28.550,-0.610,-2.092%)、千金药业(9.430,-0.100,-1.049%)、中新药业(21.310,-0.120,-0.560%)等跟跌。
2021-04-23复盘:普遍报涨
片仔癀(344.810,11.150,3.342%)领涨,特一药业(13.900,0.150,1.091%)、中新药业(21.430,0.060,0.281%)等跟涨。
2021-04-22复盘:普遍报跌
片仔癀(333.660,-3.340,-0.991%)领跌,同仁堂(29.320,-0.010,-0.034%)等跟跌。
2021-04-21复盘:普遍报涨
特一药业(12.500,1.140,10.035%)领涨,中新药业(20.540,1.290,6.701%)、嘉应制药(6.820,0.240,3.647%)等跟涨。
2021-04-20复盘:普遍报涨
嘉应制药(6.580,0.170,2.652%)领涨,特一药业(11.360,0.140,1.248%)、同仁堂(29.310,0.270,0.930%)等跟涨。
2021-04-19复盘:普遍报涨
片仔癀(328.990,19.990,6.469%)领涨,嘉应制药(6.410,0.170,2.724%)、同仁堂(29.060,0.170,0.588%)、千金药业(9.390,0.040,0.428%)等跟涨。
2021-04-16复盘:普遍报跌
片仔癀(309.000,-2.800,-0.898%)领跌,特一药业(11.230,-0.020,-0.178%)等跟跌。
2021-04-15复盘:普遍报跌
同仁堂(27.960,-0.940,-3.253%)领跌,片仔癀(311.800,-2.700,-0.859%)等跟跌。
2021-04-14复盘:普遍报涨
千金药业(8.970,0.130,1.471%)领涨,嘉应制药(5.630,0.070,1.259%)、片仔癀(314.500,3.260,1.047%)等跟涨。
2021-04-13复盘:普遍报涨
片仔癀(311.240,2.940,0.954%)领涨,千金药业(8.840,0.020,0.227%)、嘉应制药(5.560,0.010,0.180%)等跟涨。
2021-04-12复盘:普遍报跌
片仔癀(308.300,-16.770,-5.159%)领跌,中新药业(19.190,-0.230,-1.184%)、千金药业(8.820,-0.100,-1.121%)、嘉应制药(5.550,-0.030,-0.538%)、特一药业(11.150,-0.010,-0.090%)等跟跌。
2021-04-09复盘:普遍报跌
片仔癀(325.070,-6.920,-2.084%)领跌,中新药业(19.420,-0.310,-1.571%)等跟跌。
2021-04-08复盘:普遍报涨
片仔癀(331.990,3.640,1.109%)领涨,同仁堂(28.900,0.140,0.487%)等跟涨。
2021-04-07复盘:普遍报涨
片仔癀(328.350,23.140,7.582%)领涨,嘉应制药(5.570,0.220,4.112%)、特一药业(11.160,0.050,0.450%)、千金药业(8.950,0.010,0.112%)等跟涨。
2021-04-06复盘:普遍报跌
同仁堂(28.960,-0.440,-1.497%)领跌,片仔癀(305.210,-3.790,-1.227%)、特一药业(11.110,-0.010,-0.090%)等跟跌。
2021-04-01复盘:普遍报涨
片仔癀(294.360,7.400,2.579%)领涨,千金药业(8.900,0.050,0.565%)、同仁堂(29.970,0.020,0.067%)等跟涨。
本文相关数据仅供参考,不对您构成任何投资建议。用户应基于自己的独立判断,自行决定证券投资并承担相应风险。股市有风险,投资需谨慎。